Pharmacology, Toxicology and Pharmaceutical Science
HIV
96%
Pharmacokinetics
91%
Rifampicin
86%
Dolutegravir
64%
Randomized Controlled Trial
60%
Urinary Tract Infection
54%
Infection
54%
Antimicrobial Resistance
54%
Antibiotics
43%
Tuberculostatic Agent
42%
Biological Marker
38%
Isoniazid
37%
Lung Tuberculosis
37%
Diseases
36%
Adverse Drug Reaction
36%
Bedaquiline
33%
Medicine and Dentistry
Urinary Tract Infection
98%
Antibiotic Resistance
84%
Randomized Controlled Trial
51%
Antibiotics
44%
Mycobacterium Tuberculosis
33%
Immunology and Microbiology
Mycobacterium Tuberculosis
100%
Sputum
71%
Urinary Tract
53%
Bacterial Load
41%
Antimicrobial Resistance
35%